EPO Patents = 2

Forward Citations = 0

Loading Chart...

12 inventors (with patents filed for the assignee):

Yunfu Luo (2 out of 41 patents)

Peng Zhang (1 out of 112 patents)

Guoli Zhang (1 out of 6 patents)

4. Sheng Su (1 out of 5 patents)

5. Feng Gao (1 out of 34 patents)

6. Yuan Chen (1 out of 6 patents)

7. Shuhui Chen (235 patents)

8. Charles Z Ding (56 patents)

9. Zhigang Huang (8 patents)

10. Xiawei Wei (6 patents)

11. Yuquan Wei (24 patents)

12. Yong Wang (58 patents)

2 patents: Sort by Forward Citations

1. 12679845 - Crystal form of triazolopyridine-substituted indazole compound and preparation method therefor (2026-07-14),

2. 12577235 - Crystalline form of CXCR2 antagonist and application thereof (2026-03-17),

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

2 Patents

#2,028 in Shenzhen

#11,632 in China

Shenzhen, China

Shenzhen Optimum Biological Technology Co., Ltd

Forward Citations = 0

12 inventors:

Yunfu Luo (2 out of 41 patents)

Peng Zhang (1 out of 112 patents)

Guoli Zhang (1 out of 6 patents)

4. Sheng Su (1 out of 5 patents)

5. Feng Gao (1 out of 34 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Shenzhen Optimum Biological Technology Co., Ltd. Retrieved from https://idiyas.com/company/shenzhen-optimum-biological-technology

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]